interleukin-6 receptor — Drug Target

All drugs that target interleukin-6 receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

monoclonal antibody · Interleukin-6 Receptor Antagonist [EPC]

Marketed (2)

• tocilizumab or sarilumab · Pfizer · monoclonal antibody · Immunology
• Roactemra · Roche · Interleukin-6 Receptor Antagonist [EPC] · Oncology
  Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation.